Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia

AIDS

Volumn 29, Issue 3, 2015, Pages 361-371

  Denison, Julie A ^a,b   Koole, Olivier ^c,d   Tsui, Sharon ^a   Menten, Joris ^c   Torpey, Kwasi ^a   Van Praag, Eric ^a   Mukadi, Ya Diul ^a   Colebunders, Robert ^c,e   Auld, Andrew F ^f   Agolory, Simon ^f   Kaplan, Jonathan E ^f   Mulenga, Modest ^g   Kwesigabo, Gideon P ^h   Wabwire Mangen, Fred ⁱ   Bangsberg, David R ^j  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^h MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

ⁱ MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Antiretroviral therapy; HIV AIDS; Medication adherence; Sub Saharan Africa; Tanzania; Uganda; Zambia

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; STIGMA; TANZANIA; TRADITIONAL HEALER; UGANDA; ZAMBIA; ADOLESCENT; ALCOHOLISM; BLOOD; CROSS-SECTIONAL STUDY; HIV INFECTIONS; MIDDLE AGED; SOCIAL STIGMA; TRADITIONAL MEDICINE; UTILIZATION; VIRUS LOAD; YOUNG ADULT;

ADOLESCENT; ADULT; ALCOHOLISM; ANTI-RETROVIRAL AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MEDICINE, TRADITIONAL; MIDDLE AGED; RNA, VIRAL; SOCIAL STIGMA; TANZANIA; UGANDA; VIRAL LOAD; YOUNG ADULT; ZAMBIA;

EID: 84927917403     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000543     Document Type: Article

References (65)

1. WHO. Global update on HIV treatment 2013: results, impact and opportunities:WHOreport in partnership with UNICEF and UNAIDS. Geneva, Switzerland: WHO. 2013
2. UNAIDS. report: UNAIDS report on the global AIDS epidemic 2013. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2013
3. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001; 15:1181-1183.
4. Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS (London, England) 2009; 23:1035.
5. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 2006; 43:78-84.
6. Babiker AG, Emery S, Fätkenheuer G, Gordin FM, Grund B, Lundgren JD, et al. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials 2013; 10:S5-S36.
7. Braitstein P, Brinkhof M, Dabis F, Schechter M, Boulle A, Miotti P, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367:817-824.
8. Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367:1335-1342.
9. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006; 296:679-690.
10. Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, et al. Longitudinal antiretroviral adherence in HIVR Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 2009; 13:82-91.
11. Parruti G, Manzoli L, Toro PM, D'amico G, Rotolo S, Graziani V, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse. AIDS Pat Care STDs 2006; 20:48-56.
12. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus: infected persons in clinical trials. Clin Infect Dis 2002; 34:1115-1121.
13. Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percentage adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr 2006; 41:315-322.
14. Gill CJ, Hamer DH, Simon JL, Thea DM, Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub- Saharan Africa. AIDS 2005; 19:1243-1249.
15. Mayston R, Kinyanda E, Chishinga N, Prince M, Patel V. Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: a systematic review. AIDS 2012; 26:S117-S135.
16. Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, et al. Factors associated with self-reported adherence to antiretroviral therapy in a Tanzanian setting. AIDS Care 2010; 22:381-389.
17. Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak 2012; 12:56.
18. Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav 2014; 18:1199-1223.
19. Kagee A, Remien R, Berkman A, Hoffman S, Campos L, Swartz L. Structural barriers to ART adherence in Southern Africa: challenges and potential ways forward. Glob Public Health 2011; 6:83-97.
20. Koole O, Tsui S, Wabwire-Mangen F, Kwesigabo G, Menten J, Mulenga M, et al. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia. Trop Med Int Health 2014; 19:1397-1410.
21. Chesney MA, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2000; 12:255-266.
22. Mannheimer S, Mukherjee R, Hirschhorn L, Dougherty J, Celano S, Ciccarone D, et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy. AIDS Care 2006; 18:853-861.
23. Giordano TP, Guzman D, Clark R, Charlebois E, Bangsberg D. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 2004; 5:74-79.
24. Central Statistical Office MoH, Tropical Diseases Research Centre, University of Zambia, Inc MI. Zambia Demographic and Health Survey 2007. Maryland: CSO and Macro International Inc Calverton; 2009.
25. Statistics UBo, ICF International. Uganda Demographic and Health Survey 2011. Kampala, Uganda: UBOS and Calverton; Maryland: ICF International Inc; 2012.
26. National Bureau of Statistics (NBS) [Tanzania] and ICF Macro. Tanzania demographic and health survey 2010. Dar es Salaam, Tanzania: NBS and ICF Macro. 2011.
27. Rutstein Shea O and Kiersten Johnson. The DHS wealth index. DHS Comparative Reports No.6,Calverton, Maryland: ORC Macro; 2004.
28. Simbayi LC, Kalichman S, Strebel A, Cloete A, Henda N, Mqeketo A. Internalized stigma, discrimination, and depression among men and women living with HIV/AIDS in Cape Town, South Africa. Soc Sci Med 2007; 64:1823-1831.
29. Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care 2009; 21:87-93.
30. Kaaya SF, Fawzi M, Mbwambo J, Lee B, Msamanga G, Fawzi W. Validity of the Hopkins Symptom Checklist-25 amongst HIVpositive pregnant women in Tanzania. Acta Psychiatr Scand 2002; 106:9-19.
31. Broadhead W, Gehlbach SH, De Gruy FV, Kaplan BH. The Duke-UNC Functional Social Support Questionnaire: measurement of social support in family medicine patients. Med Care 1988; 26:709-723.
32. Antelman G, Kaaya S, Wei R, Mbwambo J, Msamanga GI, Fawzi WW, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr 2007; 44:470-477.
33. Claassen J. The benefits of the CAGE as a screening tool for alcoholism in a closed rural South African community. South Afr Med J 1999; 89:976.
34. Samet JH, Phillips SJ, Horton NJ, Traphagen ET, Freedberg KA. Detecting alcohol problems in HIV-infected patients: use of the CAGE questionnaire. AIDS Res Hum Retroviruses 2004; 20:151-155.
35. Justice A, Holmes W, Gifford A, Rabeneck L, Zackin R, Sinclair G, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001; 54:S77-S90.
36. Royston P. Multiple imputation of missing values. Stata J 2004; 4:227-241.
37. Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS 2007; 21:965-971.
38. Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. AIDS 2012; 26:1415-1423.
39. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26:435-442.
40. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133:21-30
41. Gross R, BilkerWB, FriedmanHM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 2002; 16:1835-1837.
42. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M-L. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011; 11:942-951.
43. McMahon JH, Jordan MR, Kelley K, Bertagnolio S, Hong SY, Wanke CA, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis 2011; 52:493-506.
44. Ashforth A. AIDS, religious enthusiasm and spiritual insecurity in Africa. Global Pub Health 2011; 6:S132-S147.
45. Thielman NM, Ostermann J, Whetten K, Whetten R, Itemba D, Maro V, et al. Reduced adherence to antiretroviral therapy among HIV-Infected Tanzanians seeking cure from the Loliondo Healer. J Acquir Immune Defic Syndr 2014; 65:e104-e109.
46. Audet CM, Blevins M, Rosenberg C, Farnsworth S, Salato J, Fernandez J, et al. Symptomatic HIV-positive persons in rural Mozambique who first consult a traditional healer have delays in HIV testing: a cross-sectional study. J Acquir Immune Defic Syndr 2014; 66:e80-e86.
47. Audet CM, Sidat M, Blevins M, Moon TD, Vergara A, Vermund SH. HIV knowledge and health-seeking behavior in Zambezia Province, Mozambique. J Soc Asp HIV/AIDS 2012; 9:41-46.
48. Okome-Nkoumou M, Okome-Miame F, Kendjo E, Obiang G-P, Kouna P, Essola-Biba O, et al. Delay between first HIV-related symptoms and diagnosis of HIV infection in patients attending the internal medicine department of the Fondation Jeanne Ebori (FJE), Libreville, Gabon. HIV Clin Trials 2005; 6:38-42.
49. Musheke M, Bond V, Merten S. Individual and contextual factors influencing patient attrition from antiretroviral therapy care in an urban community of Lusaka, Zambia. J Int AIDS Soc 2012; 15:1-9.
50. Gourlay A, Birdthistle I, Mburu G, Iorpenda K, Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2013; 16:18588.
51. Littlewood RA, Vanable PA. A global perspective on complementary and alternative medicine use among people living with HIV/AIDS in the era of antiretroviral treatment. Curr HIV/ AIDS Rep 2011; 8:257-268.
52. George G, Chitindingu E, Gow J. Evaluating traditional healers knowledge and practices related to HIV testing and treatment in South Africa. BMC Int Health Hum Rights 2013; 13:45.
53. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav 2012; 16:2101-2118.
54. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr 2009; 52:180-202.
55. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc 2013; 16:18640.
56. Patel R, Ratner J, Gore-Felton C, Kadzirange G, Woelk G, Katzenstein D. HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe. AIDS Care 2012; 24:358-368.
57. Alonzo AA, Reynolds NR. Stigma, HIV and AIDS: an exploration and elaboration of a stigma trajectory. Soc Sci Med 1995; 41:303-315.
58. Takada S, Weiser SD, Kumbakumba E, Muzoora C, Martin JN, Hunt PW, et al. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med 2014; 48:26-37.
59. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 2009; 6:e1000011.
60. O'Laughlin KN, Wyatt MA, Kaaya S, Bangsberg DR, Ware NC. How treatment partners help: social analysis of an African adherence support intervention. AIDS Behav 2012; 16:1308-1315.
61. Mills EJ, Lester R, Ford N. Promoting long term adherence to antiretroviral treatment. BMJ 2012; 345:10.
62. Nachega JB, Uthman OA, Anderson J, Peltzer K, Wampold S, Cotton MF, et al. Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and highincome countries: a systematic review and meta-analysis. AIDS 2012; 26:2039-2052.
63. Matthews LT, Heffron R, Mugo NR, Cohen C, Hendrix C, Celum C, et al. High medication adherence during periconception periods among HIV-1-uninfected women participating in a clinical trial of antiretroviral preexposure prophylaxis. J Acquir Immune Defic Syndr 2014; 67:91-97.
64. Merten S, Kenter E, McKenzie O, Musheke M, Ntalasha H, Martin-Hilber A. Patient-reported barriers and drivers of adherence to antiretrovirals in sub-Saharan Africa: a meta-ethnography. Trop Med Int Health 2010; 15:16-33.
65. Tsai AC, Bangsberg DR, Weiser SD. Harnessing poverty alleviation to reduce the stigma of HIV in sub-Saharan Africa. PLoS Med 2013; 10:e1001557.